Skip to main navigation
Back Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Careers
    • Contact Us
  • Product Candidates
    • Pipeline
    • Rivo-cel
    • BPX-601
    • BPX-701
  • Technology
    • Overview
    • CaspaCIDe
    • GoCAR-T
    • Scientific Literature
    • Abstracts & Presentations
  • Clinical Trials
    • Rivo-cel in Blood Cancers &
      Inherited Blood Disorders
    • BPX-601 (GoCAR-T) and
      BPX-701 (TCR)
  • Investors & Media

    Investor Relations

    • Investor Center Home
    • News & Events
      • Press Releases
      • Events and Presentations
      • Corporate Presentation
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
      • Analyst Coverage
      • Investment Calculator
    • Financial Information
      • Annual Reports and Proxies
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Contact Investor Relations
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Careers
    • Contact Us
  • Product Candidates
    • Pipeline
    • Rivo-cel
    • BPX-601
    • BPX-701
    • CD19 Program
  • Technology
    • Overview
    • CaspaCIDe
    • GoCAR-T
    • Scientific Literature
    • Abstracts & Presentations
  • Clinical Trials
    • Rivo-cel in Blood Cancers &
      Inherited Blood Disorders
    • BPX-601 (GoCAR-T) and
      BPX-701 (TCR)
  • Investors & Media

    Investor Relations

    • Investor Center Home
    • News & Events
      • Press Releases
      • Events and Presentations
      • Corporate Presentation
    • Stock Information
      • Stock Quote
      • Stock Chart
      • Historical Price Lookup
      • Analyst Coverage
      • Investment Calculator
    • Financial Information
      • Annual Reports and Proxies
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Shareholder Services
      • Investor FAQ
      • Contact Investor Relations
Bellicum Pharmaceuticals, Inc. - Investors and Media

Investor Relations

  • Investor Center Home
  • News & Events
    • Press Releases
    • Events and Presentations
    • Corporate Presentation
  • Stock Information
    • Stock Quote
    • Stock Chart
    • Historical Price Lookup
    • Analyst Coverage
    • Investment Calculator
  • Financial Information
    • Annual Reports and Proxies
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Shareholder Services
    • Investor FAQ
    • Contact Investor Relations

Tools

  • Email Alerts
  • RSS Feeds
  • Print Page

Investor Center


Page Not Found

We are sorry, the page you requested cannot be found. Please check the URL or visit our Homepage.

About Us

  • Overview
  • Management Team
  • Board of Directors
  • Careers
  • Contact Us

Product Candidates

  • Pipeline
  • Rivo-cel
  • BPX-601
  • BPX-701

Technology

  • Overview
  • CaspaCIDe
  • GoCAR-T
  • Scientific Literature
  • Abstracts & Presentations

Clinical Trials

  • Rivo-cel in Blood Cancers &
    Inherited Blood Disorders
  • BPX-601 (GoCAR-T) and
    BPX-701 (TCR)

Investors & Media

IR Footer

  • Investor Center Home
  • News & Events
  • Stock Information
  • Financial Information
  • Corporate Governance
  • Shareholder Services

Copyright © 2019 Bellicum Pharmaceuticals Inc. All Rights Reserved

  • Contact Us
  • Privacy Policy
  • Terms of Use